Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Anneke D. van Dijk"'
Autor:
Fieke W. Hoff, Anneke D. van Dijk, Yihua Qiu, Chenyue W. Hu, Rhonda E. Ries, Andrew Ligeralde, Gaye N. Jenkins, Robert B. Gerbing, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Todd A. Alonzo, Soheil Meshinchi, Amina A. Qutub, Eveline S.J.M. de Bont, Terzah M. Horton, Steven M. Kornblau
Publikováno v:
Haematologica, Vol 107, Iss 10 (2022)
Pediatric acute myeloid leukemia (AML) remains a fatal disease for at least 30% of patients, stressing the need for improved therapies and better risk stratification. As proteins are the unifying feature of (epi)genetic and environmental alterations,
Externí odkaz:
https://doaj.org/article/ec910a7b013b405a849aaa5ec9509aa0
Autor:
Fieke W Hoff, Eveline S. J. M. de Bont, Kevin Ruiz, Endurance Toro, Anneke D. van Dijk, Ti’ara L. Griffen, William G. Wierda, James W. Lillard, Steven M. Kornblau, Peter P. Ruvolo, Jan A. Burger, Yihua Qiu
Publikováno v:
Leukemia, 36. Nature Publishing Group
The chronic lymphocytic leukemia (CLL) armamentarium has evolved significantly, with novel therapies that inhibit Bruton Tyrosine Kinase, PI3K delta and/or the BCL2 protein improving outcomes. Still, the clinical course of CLL patients is highly vari
Autor:
Todd A. Alonzo, Sophia W.M. Bruggeman, Richard Aplenc, Anneke D. van Dijk, Steven M. Kornblau, E. Anders Kolb, Fieke W Hoff, Eveline S. J. M. de Bont, Amanda R. Leonti, Robert B. Gerbing, Peter P. Ruvolo, Soheil Meshinchi, Yihua Qiu, Alan S. Gamis, Gaye Jenkins, Terzah M. Horton
Publikováno v:
Blood
Blood, 137(8), 1050-1060. AMER SOC HEMATOLOGY
Blood, 137(8), 1050-1060. AMER SOC HEMATOLOGY
Bortezomib (BTZ) was recently evaluated in a randomized phase 3 clinical trial by the Children’s Oncology Group (COG) that compared standard chemotherapy (cytarabine, daunorubicin, and etoposide [ADE]) vs standard therapy with BTZ (ADEB) for de nov
Publikováno v:
Expert review of proteomics. 17(1):1-10
Introduction: The biological heterogeneity of acute myeloid leukemia (AML) complicates personalized medicine. Individual prognosis is typically based on the presence of chromosomal and genetic lesions. Nevertheless, these classifications often lack a
Autor:
Todd A. Alonzo, Terzah M. Horton, Fieke W Hoff, Alan S. Gamis, Gaye Jenkins, Eveline S. J. M. de Bont, Soheil Meshinchi, Anneke D. van Dijk, Yihua Qiu, Richard Aplenc, Steven M. Kornblau, Robert B. Gerbing, E. Anders Kolb
Publikováno v:
Proteomics Clin Appl
Proteomics-Clinical Applications, 16(2):2100072. WILEY-V C H VERLAG GMBH
Proteomics-Clinical Applications, 16(2):2100072. WILEY-V C H VERLAG GMBH
Purpose: The addition of the proteasome inhibitor (PI) bortezomib to standard chemotherapy (ADE: cytarabine [Ara-C], daunorubicin, and etoposide) did not improve overall outcome of pediatric AML patients in the Children's Oncology Group AAML1031 phas
Autor:
Fieke W, Hoff, Anneke D, Van Dijk, Yihua, Qiu, Chenyue W, Hu, Rhonda E, Ries, Andrew, Ligeralde, Gaye N, Jenkins, Robert B, Gerbing, Alan S, Gamis, Richard, Aplenc, E Anders, Kolb, Todd A, Alonzo, Soheil, Meshinchi, Amina A, Qutub, Eveline S J M, De Bont, Terzah M, Horton, Steven M, Kornblau
Publikováno v:
Haematologica. 107(10)
Pediatric acute myeloid leukemia (AML) remains a fatal disease for at least 30% of patients, stressing the need for improved therapies and better risk stratification. As proteins are the unifying feature of (epi)genetic and environmental alterations,
Autor:
Anneke D, van Dijk, Ti'ara L, Griffen, Yihua H, Qiu, Fieke W, Hoff, Endurance, Toro, Kevin, Ruiz, Peter P, Ruvolo, James W, Lillard, Eveline S J M, de Bont, Jan A, Burger, William, Wierda, Steven M, Kornblau
Publikováno v:
Leukemia. 36(3)
The chronic lymphocytic leukemia (CLL) armamentarium has evolved significantly, with novel therapies that inhibit Bruton Tyrosine Kinase, PI3K delta and/or the BCL2 protein improving outcomes. Still, the clinical course of CLL patients is highly vari
Autor:
Debra J. Morrison, Anneke D. van Dijk, Gaye Jenkins, Teena Bhatla, Julia Meyer, Steven M. Kornblau, Laura Hogan, Terzah M. Horton, Qianxing Mo, Yihua Qiu, Eleny Romanos-Sirakis, William L. Carroll, Fieke W Hoff, Tao Wang
Publikováno v:
J Proteomics
Journal of proteomics, 233:104046. ELSEVIER SCIENCE BV
Journal of proteomics, 233:104046. ELSEVIER SCIENCE BV
Reverse phase protein arrays (RPPA) can assess protein expression and activation states in large numbers of samples (n>1000) and evidence suggests feasibility in the setting of multi-institution clinical trials. Despite evidence in solid tumors, litt
Autor:
Anneke D. van Dijk, Fieke W Hoff, Terzah M. Horton, Steven M. Kornblau, Yihua Qiu, Sophia W.M. Bruggeman, Eveline S. J. M. de Bont
Publikováno v:
Blood, 136. AMER SOC HEMATOLOGY
Background: Acute myeloid leukemia (AML) is an epigenetically heterogeneous disease. The intensity of treatment is currently guided by cytogenetic and molecular genetic risk classifications; however these incompletely predict outcomes, requiring addi